Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Plaquetes sanguínies"'
Autor:
Albert Ariza-Solé, Gemma Mateus-Porta, Francesc Formiga, Sergio Garcia-Blas, Clara Bonanad, Iván Núñez-Gil, Carlos Vergara-Uzcategui, Pablo Díez-Villanueva, Jordi Bañeras, Clara Badia-Molins, Jaime Aboal, José Carreras-Mora, Ana Gabaldón-Pérez, José Antonio Parada-Barcia, Manuel Martínez-Sellés, Josep Comín-Colet, Sergio Raposeiras-Roubin
Publikováno v:
Scientia
Background Current guidelines recommend extending the use of dual antiplatelet therapy (DAPT) beyond 1 year in patients with an acute coronary syndrome (ACS) and a high risk of ischaemia and low risk of bleeding. No data exist about the implementatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84693290112b765fba90f0f62195992
http://hdl.handle.net/2445/196043
http://hdl.handle.net/2445/196043
Autor:
Merchán-Galvis, Angela, Anaya, Rafael, Rodriguez, Mireia, Llorca, Jordi, Castejón, Mercé, Gil, José María, Millan, Angélica, Estepa, Verónica, Cardona, Elena, Garcia-Sanchez, Yaiza, Ruiz, Ana, Martinez-Zapata, Maria Jose, Group, AFFEcT Study Group AFFEcT Study
Publikováno v:
Scientia
Journal of Clinical Medicine
Volume 12
Issue 3
Pages: 1130
Journal of Clinical Medicine
Volume 12
Issue 3
Pages: 1130
Antiplatelet drugs; Femur fracture; Randomized clinical trial Fármacos antiplaquetarios; Fractura de fémur; Ensayo clínico aleatorizado Medicaments antiplaquetaris; Fractura de fèmur; Assaig clínic aleatoritzat Background: We evaluated a strateg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87145513ade22be25afe33bf6ee90c8
https://hdl.handle.net/11351/9131
https://hdl.handle.net/11351/9131
Autor:
Pereyra, Eduardo, Fernández-Rodríguez, Diego, González-Sucarrats, Silvia, Almendro-Delia, Manuel, Martín, Agustín, de Miguel, Irene Martin, Andrés, Mireia, Duran-Cambra, Alberto, Sánchez-Grande-Flecha, Alejandro, Worner-Diz, Fernando, Núñez-Gil, Iván J, RETAKO investigators
Publikováno v:
Scientia
Síndrome de Takotsubo; Disfunción endotelial; Tratamiento antiplaquetario Síndrome de Takotsubo; Disfunció endotelial; Tractament antiplaquetari Takotsubo syndrome; Endothelial dysfunction; Antiplatelet treatment Introduction Endothelial dysfunct
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::346add7f7dab3b21fee11bcba5fb2a4c
https://hdl.handle.net/11351/8826
https://hdl.handle.net/11351/8826
Autor:
Anaís Mariscal, Carlos Zamora, César Díaz-Torné, Mᵃ Àngels Ortiz, Juan José de Agustín, Delia Reina, Paula Estrada, Patricia Moya, Héctor Corominas, Sílvia Vidal
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 10; Pages: 5748
Scientia
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Scientia
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Monocytes; Rheumatoid arthritis; Tocilizumab Monocitos; Artritis reumatoide; Tocilizumab Monòcits; Artritis reumatoide; Tocilizumab Platelets (PLT) bind to a significant percentage of circulating monocytes and this immunomodulatory interaction is in
Autor:
Clara Bonanad, Sergio Raposeiras-Roubin, Sergio García-Blas, Iván Núñez-Gil, Carlos Vergara-Uzcategui, Pablo Díez-Villanueva, Jordi Bañeras, Clara Badía Molins, Jaime Aboal, Jose Carreras, Vicente Bodi, Ana Gabaldón-Pérez, Gemma Mateus-Porta, Jose Antonio Parada Barcia, Manuel Martínez-Sellés, Francisco Javier Chorro, Albert Ariza-Solé
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Scientia
Journal of Clinical Medicine; Volume 11; Issue 6; Pages: 1680
Universidad de Barcelona
Scientia
Journal of Clinical Medicine; Volume 11; Issue 6; Pages: 1680
Acute coronary syndrome; Dual antiplatelet therapy; Ischemic risk Síndrome coronario agudo; Terapia antiplaquetaria dual; Riesgo isquémico Síndrome coronària aguda; Teràpia antiplaquetària dual; Risc isquèmic Clinical practice guidelines recom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee102503238483a0de46d9863805b49
http://hdl.handle.net/2445/185022
http://hdl.handle.net/2445/185022
Autor:
Anaya, Rafael, Rodriguez, Mireia, Millan, Angélica, Reguant, Francesca, Llorca, Jordi, Guilabert, Patricia, Ruiz, Ana, Pantoja, Percy-Efrain, Gil, José María, Moral, Victoria, Merchán-Galvis, Angela, Martinez-Zapata, Maria Jose, Group, on behalf of the AFFEcT Study Group on behalf of the AFFEcT Study
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 22
Scientia
Journal of Clinical Medicine, Vol 10, Iss 5371, p 5371 (2021)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Volume 10
Issue 22
Scientia
Journal of Clinical Medicine, Vol 10, Iss 5371, p 5371 (2021)
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background: Patients with proximal femur fracture on antiplatelet treatment benefit from early surgery. Our goal was to perform early surgery under neuraxial anaesthesia when indicated by the platelet function test. Methods: We conducted a multicentr
Autor:
Yongjun Wang, Yuesong Pan, Hao Li, Pierre Amarenco, Hans Denison, Scott R. Evans, Anders Himmelmann, Stefan James, Mikael Knutsson, Per Ladenvall, Carlos A. Molina, S. Claiborne Johnston
Publikováno v:
Scientia
Background and ObjectivesThe goal of this work was to investigate the short-term time-course benefit and risk of ticagrelor with aspirin in acute mild-moderate ischemic stroke or high-risk TIA in The Acute Stroke or Transient Ischemic Attack Treated
Autor:
[Ribera A, Ferreira-Gonzalez I, Marsal JR] Servei de Cardiologia, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Centro de Investigación Biomédica en Red en Epidemiología y Salud Pública (CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. [Oristrell G, Garcia Dorado D] Servei de Cardiologia, Hospital Universitari Vall d’Hebron, Barcelona, Spain. Centro de Investigación Biomédica en Red para Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. [Faixedas MT] Servei Català de la Salut, Generalitat de Catalunya, Barcelona, Spain. [Rosas A] Departament de Salut, Generalitat de Catalunya, Barcelona, Spain., Hospital Universitari Vall d'Hebron
Publikováno v:
Scientia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______272::3bee22b421280430546c1b48ecd2afe3
https://hdl.handle.net/2072/433791
https://hdl.handle.net/2072/433791
Autor:
Hernández Enríquez, Marco
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
TDX (Tesis Doctorals en Xarxa)
TDR. Tesis Doctorales en Red
instname
TDR: Tesis Doctorales en Red
CBUC, CESCA
Universidad de Barcelona
TDX (Tesis Doctorals en Xarxa)
TDR. Tesis Doctorales en Red
instname
TDR: Tesis Doctorales en Red
CBUC, CESCA
[eng] INTRODUCTION: TAVI has settled as the standard of care of AS for inoperable, high-risk, and selected intermediate-risk patients undergoing aortic valve replacement. Vascular and bleeding complications are related to worst outcomes. HYPOTHESES:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::789a40b885ebe93dda282b7ea51f10c3
http://hdl.handle.net/2445/171683
http://hdl.handle.net/2445/171683
Publikováno v:
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Universitat Autònoma de Barcelona
Pòster Juny
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::46772acf95adebafd58b91c2435b88f8
https://ddd.uab.cat/record/233333
https://ddd.uab.cat/record/233333